MedWatch

Pandemic kicked off ALK's digitization process

The world's ongoing pandemic has accelerated allergy company ALK's digital efforts, in which the firm has invested a massive million-kroner figure. "Digitally, we're in the loop," states the CEO, who has turned digitization into a company focus area.

Photo: ALK / PR

Digital apps, online tools and consumer behavior tracking are some of the initiatives which will raise allergy patient awareness of tablet vaccines from the Danish company.

This was the tune, when ALK CEO Carsten Hellmann launched an encompassing transformation of the firm in December 2018, which included a growth plan where digitization was one of four central strategic action areas.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs